Gestational Weight Gain Influences the Adipokine-Oxidative Stress Association during Pregnancy
Juan Mario Solis Paredes1, Otilia Perichart Perera2, Araceli Montoya Estrada3
1Department of Human Genetics and Genomics, Instituto Nacional de Perinatologia, Mexico City, Mexico.
Insights
Excessive gestational weight gain in pregnancy is linked to altered adipokine levels and increased oxidative stress markers. These changes in adipokines and oxidative stress are associated with abnormal adipose tissue accumulation during pregnancy.
Area of Science:
- Reproductive biology
- Metabolic health
- Biochemistry
Background:
- Gestational weight gain (GWG) significantly impacts maternal and infant health.
- Excessive GWG is associated with adverse outcomes like gestational diabetes and future obesity.
- Adipose tissue dysfunction and oxidative stress are implicated in abnormal GWG.
Purpose of the Study:
- To investigate the relationship between adipokines and oxidative stress markers in pregnant women.
- To determine how gestational weight gain influences these associations.
Main Methods:
- Maternal serum samples were collected in the third trimester (n=74).
- Assayed adipokines (adiponectin, leptin, resistin) and oxidative stress markers (8-oxodG, LOOH, MDA, CP).
- Measured glucose as a metabolic marker.
Main Results:
- Women with excessive GWG had lower adiponectin levels.
- Adiponectin correlated with 8-oxodG in adequate/insufficient GWG groups, but not in excessive GWG.
- Leptin was positively associated with oxidative markers (LOOH, MDA, CP) in excessive GWG.
Conclusions:
- Adipokine production and oxidative stress are concurrently regulated in pregnancy.
- Gestational weight gain, particularly excessive gain, influences this regulation.
- Excessive adipose tissue accumulation likely plays a role in these altered associations.
Introduction And Objective:
The weight gained during pregnancy could determine the immediate and future health of the mother-child dyad. Excessive gestational weight gain (EGWG) due to abnormal adipose tissue (AT) accumulation is strongly associated with adverse perinatal outcomes as gestational diabetes, macrosomia, obesity, and hypertension further in life. Dysregulation of adipokine, AT dysfunction, and an imbalance in the prooxidant-antioxidant systems are critical features in altered AT accumulation. This study was aimed to investigate the association between adipokines and oxidative stress markers in pregnant women and the influence of the GWG on this association.
Methods:
Maternal blood samples were obtained in the third trimester of pregnancy (n = 74) and serum adipokines (adiponectin, leptin, and resistin), oxidative damage markers: 8-oxo-2'-deoxyguanosine (8-oxodG), lipohydroperoxides (LOOH), malondialdehyde (MDA), and carbonylated proteins (CP), and glucose a metabolic marker were measured.
Results:
Women with EGWG had low adiponectin levels than women with adequate weight gain (AWG) or insufficient weight gain (IWG). Multiple linear regression models revealed a positive association between adiponectin and 8-oxodG in women with AWG (B = 1.09, 95% CI: 164-222, p = 0.027) and IWG (B = 0.860, 95% CI: 0.199-1.52, p = 0.013) but not in women with EGWG. In women with EGWG, leptin was positively associated with LOOH (p = 0.018), MDA (p = 0.005), and CP (p = 0.010) oxidative markers.
Conclusion:
Our findings suggest that concurrent mechanisms regulate adipokine production and oxidative stress in pregnant women and that this regulation is influenced by GWG, probably due to an excessive AT accumulation.
More Related Videos
06:39Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
14:40Instrumentation of Near-term Fetal Sheep for Multivariate Chronic Non-anesthetized Recordings
Published on: October 25, 2015
Related Concept Videos
Obesity
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Psychoneuroimmunology: Diabetes and Cancer
